Serum FAM19A5 in newly diagnosed type 2 diabetes mellitus and its association with metabolic and inflammatory parameters: A case-control study.
We aimed to investigate serum levels of FAM19A5, a novel adipokine implicated in inflammation and metabolic regulation, and to examine its association with key metabolic and inflammatory markers in individuals newly diagnosed with type 2 diabetes mellitus (T2DM). This case-control study included 54 patients with newly...